|
CA2516320C
(en)
|
2003-02-18 |
2015-05-26 |
Kevin Slawin |
Induced activation in dendritic cells
|
|
US7959659B2
(en)
|
2004-01-02 |
2011-06-14 |
Advanced Cardiovascular Systems, Inc. |
High-density lipoprotein coated medical devices
|
|
CA2666667C
(en)
*
|
2006-10-19 |
2023-06-20 |
Baylor College Of Medicine |
Generating an immune response by inducing cd40 and pattern recognition receptors
|
|
EP2331680B1
(en)
*
|
2008-09-22 |
2017-05-03 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
|
|
AU2011239569B2
(en)
*
|
2010-04-16 |
2014-07-24 |
Baylor College Of Medicine |
Method for treating solid tumors
|
|
WO2011146862A1
(en)
|
2010-05-21 |
2011-11-24 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing selective apoptosis
|
|
WO2012112945A1
(en)
*
|
2011-02-18 |
2012-08-23 |
The Trustees Of Columbia University In The City Of New York |
Use of matrix metalloproteinase inhibitors to treat tuberculosis
|
|
ES3005912T3
(en)
|
2011-07-22 |
2025-03-17 |
Csl Behring Gmbh |
Inhibitory anti-factor xii/xiia monoclonal antibodies and their uses
|
|
ES2686526T3
(es)
|
2011-12-05 |
2018-10-18 |
Trellis Bioscience, Llc |
Anticuerpos útiles en la inmunización pasiva contra la influenza
|
|
US9220759B2
(en)
*
|
2012-02-23 |
2015-12-29 |
Abbott Cardiovascular Systems Inc. |
Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
|
|
US9220584B2
(en)
|
2012-03-30 |
2015-12-29 |
Abbott Cardiovascular Systems Inc. |
Treatment of diabetic patients with a stent and locally administered adjunctive therapy
|
|
PL3685855T3
(pl)
*
|
2012-10-05 |
2024-04-08 |
Kadmon Corporation, Llc |
Ludzkie przeciwciała anty-vegfr-2/kdr
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
US11827693B2
(en)
|
2013-03-14 |
2023-11-28 |
Contrafect Corporation |
Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy
|
|
WO2014151960A2
(en)
|
2013-03-14 |
2014-09-25 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
|
CA2912172A1
(en)
|
2013-06-05 |
2014-12-11 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
|
TWI775117B
(zh)
*
|
2013-08-05 |
2022-08-21 |
德商伊瑪提克斯生物科技有限公司 |
新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物（二）
|
|
PL3456339T3
(pl)
|
2013-08-05 |
2022-03-21 |
Immatics Biotechnologies Gmbh |
Nowa immunoterapia przeciwko szeregu nowotworom, takim jak rak płuc, w tym nsclc
|
|
JP6712428B2
(ja)
|
2014-02-04 |
2020-06-24 |
コントラフェクト コーポレイション |
インフルエンザ受動免疫に有用な抗体ならびにその使用のための組成物、組合せおよび方法
|
|
US10639370B2
(en)
|
2014-02-04 |
2020-05-05 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
US10934346B2
(en)
|
2014-02-14 |
2021-03-02 |
Bellicum Pharmaceuticals, Inc. |
Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12
|
|
EP2907512A1
(en)
|
2014-02-14 |
2015-08-19 |
Commissariat A L'energie Atomique Et Aux Energies Alternatives |
Inhibitors of MMP-12 as antiviral Agents
|
|
HUE051676T2
(hu)
*
|
2014-04-08 |
2021-03-29 |
Boston Pharmaceuticals Inc |
Il-21-re specifikus kötõ molekulák és alkalmazásaik
|
|
US10888608B2
(en)
|
2014-09-02 |
2021-01-12 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides
|
|
ES2904301T3
(es)
|
2014-11-03 |
2022-04-04 |
Academisch Ziekenhuis Leiden H O D N Leids Univ Medisch Centrum |
Receptores de células T dirigidos contra Bob1 y usos de los mismos
|
|
TWI909341B
(zh)
|
2015-09-24 |
2025-12-21 |
日商第一三共股份有限公司 |
抗garp抗體及其製造方法及用途
|
|
EP3410849B1
(en)
*
|
2016-02-05 |
2023-07-05 |
Institut Pasteur |
Use of inhibitors of adam12 as adjuvants in tumor therapies
|
|
JP2018105726A
(ja)
*
|
2016-12-27 |
2018-07-05 |
株式会社国際電気通信基礎技術研究所 |
心筋梗塞、認知症、および腫瘍からなる群から選択される一種を予防、または治療するための有効成分の候補物質のスクリーニング装置、スクリーニングプログラム、およびスクリーニング方法
|
|
KR102715540B1
(ko)
|
2017-03-14 |
2024-10-08 |
파이브 프라임 테라퓨틱스, 인크. |
산성 pH에서 VISTA에 결합하는 항체
|
|
CN118772278A
(zh)
|
2017-06-02 |
2024-10-15 |
辉瑞公司 |
Flt3的特异性抗体及其用途
|
|
BR112020019083A2
(pt)
|
2018-03-21 |
2020-12-29 |
Five Prime Therapeutics, Inc. |
Anticorpos, ácido nucleico, composições, célula e métodos para preparar um anticorpo, para tratar câncer, para tratar uma doença infecciosa, para tratar uma inflamação, para a identificação de um anticorpo, para melhorar a eficácia antitumoral de um anticorpo, para melhorar a farmacocinética de um anticorpo, para selecionar um anticorpo, para melhorar a eficácia de anticorpos, para isolar anticorpos, para detectar vista em uma amostra e para tratar câncer
|
|
BR112021000303A2
(pt)
|
2018-07-11 |
2021-04-13 |
Five Prime Therapeutics, Inc. |
Anticorpos que se ligam a vista em ph ácido
|
|
US11332546B2
(en)
*
|
2019-05-21 |
2022-05-17 |
The Regents Of The University Of California |
Protease inhibitory antibodies and methods of use thereof
|
|
WO2021222595A2
(en)
*
|
2020-04-30 |
2021-11-04 |
Virtuoso Binco, Inc. |
Multispecific antibodies targeting cd38 and epcam and uses thereof
|
|
WO2021229306A2
(en)
*
|
2020-05-12 |
2021-11-18 |
Virtuoso Binco,Inc. |
Multispecific antibodies targeting cd38 and bcma and uses thereof
|
|
US20230391854A1
(en)
*
|
2020-09-09 |
2023-12-07 |
Innovent Biologics (Suzhou) Co., Ltd. |
Monoclonal antibody for coronavirus spike protein, and use thereof
|
|
WO2022266039A1
(en)
*
|
2021-06-16 |
2022-12-22 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Systems and methods for monitoring and treating stroke
|
|
CN120129835A
(zh)
*
|
2022-10-28 |
2025-06-10 |
庆应义塾 |
以mmp12为指标的免疫介导的炎症性疾病的诊断、以及基于抑制mmp12的免疫介导的炎症性疾病的治疗用药物
|
|
CN118530365B
(zh)
*
|
2024-06-18 |
2025-03-11 |
辽宁得康药业集团有限公司 |
特异性检测mmp12蛋白的单克隆抗体及其应用
|